{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:16:41Z","timestamp":1742807801206},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,8]]},"DOI":"10.7759\/cureus.68933","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:36:06Z","timestamp":1725802566000},"source":"Crossref","is-referenced-by-count":1,"title":["Precision Imaging in Neurodegeneration: The Superiority of Diffusion Tensor Imaging Over Conventional MRI in Differentiating Parkinson\u2019s Disease From Atypical Parkinsonian Syndromes"],"prefix":"10.7759","author":[{"given":"Jasvant Ram","family":"Ananthasayanam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth","family":"Anandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunkumar","family":"Mohanakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerthi","family":"Charitha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26968","article-title":"The role of high-field magnetic resonance imaging in parkinsonian disorders: pushing the boundaries forward","volume":"32","author":"Lehericy S","year":"2017","unstructured":"Lehericy S, Vaillancourt DE, Seppi K, et al.. The role of high-field magnetic resonance imaging in parkinsonian disorders: pushing the boundaries forward. Mov Disord. 2017, 32:510-25. 10.1002\/mds.26968","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203341","article-title":"Imaging the substantia nigra in Parkinson disease and other parkinsonian syndromes","volume":"300","author":"Bae YJ","year":"2021","unstructured":"Bae YJ, Kim JM, Sohn CH, et al.. Imaging the substantia nigra in Parkinson disease and other parkinsonian syndromes. Radiology. 2021, 300:260-78. 10.1148\/radiol.2021203341","journal-title":"Radiology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000578","article-title":"MRI-based neuroimaging: atypical parkinsonisms and other movement disorders","volume":"31","author":"Kassubek J","year":"2018","unstructured":"Kassubek J. MRI-based neuroimaging: atypical parkinsonisms and other movement disorders. Curr Opin Neurol. 2018, 31:425-30. 10.1097\/WCO.0000000000000578","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26883","article-title":"Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta","volume":"32","author":"Langley J","year":"2017","unstructured":"Langley J, Huddleston DE, Sedlacik J, Boelmans K, Hu XP. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta. Mov Disord. 2017, 32:441-9. 10.1002\/mds.26883","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.572976","article-title":"Neuroimaging advances in Parkinson's disease and atypical parkinsonian syndromes","volume":"11","author":"Saeed U","year":"2020","unstructured":"Saeed U, Lang AE, Masellis M. Neuroimaging advances in Parkinson's disease and atypical parkinsonian syndromes. Front Neurol. 2020, 11:10.3389\/fneur.2020.572976","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn195","article-title":"Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease","volume":"131","author":"Rizzo G","year":"2008","unstructured":"Rizzo G, Martinelli P, Manners D, et al.. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain. 2008, 131:2690-700. 10.1093\/brain\/awn195","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pjnns.2015.10.002","article-title":"The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice","volume":"49","author":"D\u0105browska M","year":"2015","unstructured":"D\u0105browska M, Schinwelski M, Sitek EJ, Muraszko-Klaudel A, Brockhuis B, Jamrozik Z, S\u0142awek J. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice. Neurol Neurochir Pol. 2015, 49:421-31. 10.1016\/j.pjnns.2015.10.002","journal-title":"Neurol Neurochir Pol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12067","article-title":"Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools","volume":"127","author":"Liscic RM","year":"2013","unstructured":"Liscic RM, Srulijes K, Gr\u00f6ger A, Maetzler W, Berg D. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools. Acta Neurol Scand. 2013, 127:362-70. 10.1111\/ane.12067","journal-title":"Acta Neurol Scand"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams DR","year":"2005","unstructured":"Williams DR, de Silva R, Paviour DC, et al.. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. 2005, 128:1247-58. 10.1093\/brain\/awh488","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa E","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021, 20:385-97. 10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-4-371","article-title":"Imaging in Parkinson's disease","volume":"16","author":"Pagano G","year":"2016","unstructured":"Pagano G, Niccolini F, Politis M. Imaging in Parkinson's disease. Clin Med (Lond). 2016, 16:371-5. 10.7861\/clinmedicine.16-4-371","journal-title":"Clin Med (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.10.002","article-title":"MRI biomarkers of motor and non-motor symptoms in Parkinson's disease","volume":"73","author":"Ryman SG","year":"2020","unstructured":"Ryman SG, Poston KL. MRI biomarkers of motor and non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2020, 73:85-93. 10.1016\/j.parkreldis.2019.10.002","journal-title":"Parkinsonism Relat Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00437-1","article-title":"Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson's disease","volume":"8","author":"Shen T","year":"2022","unstructured":"Shen T, Yue Y, Ba F, et al.. Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson's disease. NPJ Parkinsons Dis. 2022, 8:10.1038\/s41531-022-00437-1","journal-title":"NPJ Parkinsons Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.S1-001","article-title":"Magnetic resonance imaging (MRI) in Parkinson's disease","volume":"1","author":"Tuite PJ","year":"2013","unstructured":"Tuite PJ, Mangia S, Michaeli S. Magnetic resonance imaging (MRI) in Parkinson's disease. J Alzheimers Dis Parkinsonism. 2013, 1:10.4172\/2161-0460.S1-001","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci7060068","article-title":"Brain magnetic resonance imaging (MRI) as a potential biomarker for Parkinson's disease (PD)","volume":"7","author":"Tuite P","year":"2017","unstructured":"Tuite P. Brain magnetic resonance imaging (MRI) as a potential biomarker for Parkinson's disease (PD). Brain Sci. 2017, 7:10.3390\/brainsci7060068","journal-title":"Brain Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/207624","article-title":"Diffusion kurtosis imaging of substantia nigra is a sensitive method for early diagnosis and disease evaluation in Parkinson\u2019s disease","volume":"2015","author":"Zhang G","year":"2015","unstructured":"Zhang G, Zhang Y, Zhang C, et al.. Diffusion kurtosis imaging of substantia nigra is a sensitive method for early diagnosis and disease evaluation in Parkinson\u2019s disease. Parkinsons Dis. 2015, 2015:10.1155\/2015\/207624","journal-title":"Parkinsons Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002461","article-title":"Age at onset and Parkinson disease phenotype","volume":"86","author":"Pagano G","year":"2016","unstructured":"Pagano G, Ferrara N, Brooks DJ, Pavese N. Age at onset and Parkinson disease phenotype. Neurology. 2016, 86:1400-7. 10.1212\/WNL.0000000000002461","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15516","article-title":"The role of neuroimaging in Parkinson's disease","volume":"159","author":"Bidesi NS","year":"2021","unstructured":"Bidesi NS, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM. The role of neuroimaging in Parkinson's disease. J Neurochem. 2021, 159:660-89. 10.1111\/jnc.15516","journal-title":"J Neurochem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-200203000-00018","article-title":"Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease","volume":"26","author":"Righini A","year":"2002","unstructured":"Righini A, Antonini A, Ferrarini M, de Notaris R, Canesi M, Triulzi F, Pezzoli G. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr. 2002, 26:266-71. 10.1097\/00004728-200203000-00018","journal-title":"J Comput Assist Tomogr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120220","article-title":"Nuclear imaging in Parkinson's disease: the past, the present, and the future","volume":"436","author":"Golan H","year":"2022","unstructured":"Golan H, Volkov O, Shalom E. Nuclear imaging in Parkinson's disease: the past, the present, and the future. J Neurol Sci. 2022, 436:10.1016\/j.jns.2022.120220","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.226460","article-title":"Neuroimaging in parkinsonian disorders","volume":"66","author":"Tripathi M","year":"2018","unstructured":"Tripathi M, Kumar A, Bal C. Neuroimaging in parkinsonian disorders. Neurol India. 2018, 66:68-78. 10.4103\/0028-3886.226460","journal-title":"Neurol India"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/291775-precision-imaging-in-neurodegeneration-the-superiority-of-diffusion-tensor-imaging-over-conventional-mri-in-differentiating-parkinsons-disease-from-atypical-parkinsonian-syndromes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:36:11Z","timestamp":1725802571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/291775-precision-imaging-in-neurodegeneration-the-superiority-of-diffusion-tensor-imaging-over-conventional-mri-in-differentiating-parkinsons-disease-from-atypical-parkinsonian-syndromes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,8]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.68933","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,8]]}}}